Shares of Transenterix Inc (NASDAQ:TRXC) gapped up before the market opened on Thursday . The stock had previously closed at $2.77, but opened at $2.69. Transenterix shares last traded at $2.79, with a volume of 4441816 shares.

A number of analysts recently weighed in on the stock. Ladenburg Thalmann Financial Services set a $5.00 target price on shares of Transenterix and gave the stock a “buy” rating in a report on Friday, October 20th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $4.00 price objective (up previously from $3.75) on shares of Transenterix in a research note on Monday, October 30th. Finally, Zacks Investment Research lowered shares of Transenterix from a “buy” rating to a “sell” rating in a research note on Tuesday, August 8th.

In related news, insider Todd Pope sold 600,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 18th. The shares were sold at an average price of $3.68, for a total value of $2,208,000.00. Following the completion of the transaction, the insider now owns 462,644 shares of the company’s stock, valued at approximately $1,702,529.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

A number of hedge funds have recently added to or reduced their stakes in TRXC. Sabby Management LLC purchased a new stake in Transenterix in the 2nd quarter worth approximately $2,456,000. Goldman Sachs Group Inc. lifted its position in Transenterix by 7,137.7% in the 2nd quarter. Goldman Sachs Group Inc. now owns 1,203,199 shares of the company’s stock worth $854,000 after buying an additional 1,186,575 shares in the last quarter. UBS Oconnor LLC purchased a new stake in Transenterix in the 2nd quarter worth approximately $390,000. LMR Partners LLP purchased a new stake in Transenterix in the 2nd quarter worth approximately $189,000. Finally, Global X Management Co. LLC lifted its position in Transenterix by 238.3% in the 2nd quarter. Global X Management Co. LLC now owns 331,075 shares of the company’s stock worth $235,000 after buying an additional 233,213 shares in the last quarter.

ILLEGAL ACTIVITY WARNING: This piece of content was published by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/transenterix-inc-trxc-shares-gap-up-to-2-69/1695688.html.

About Transenterix

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Receive News & Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.